Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 4
1996 2
1997 2
1998 6
1999 1
2000 3
2001 2
2007 1
2017 1
2020 1
2021 3
2022 2
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Data capture and sharing in the COVID-19 pandemic: a cause for concern.
Dron L, Kalatharan V, Gupta A, Haggstrom J, Zariffa N, Morris AD, Arora P, Park J. Dron L, et al. Among authors: zariffa n. Lancet Digit Health. 2022 Oct;4(10):e748-e756. doi: 10.1016/S2589-7500(22)00147-9. Lancet Digit Health. 2022. PMID: 36150783 Free PMC article. Review.
Streamlining cardiovascular clinical trials to improve efficiency and generalisability.
Zannad F, Pfeffer MA, Bhatt DL, Bonds DE, Borer JS, Calvo-Rojas G, Fiore L, Lund LH, Madigan D, Maggioni AP, Meyers CM, Rosenberg Y, Simon T, Stough WG, Zalewski A, Zariffa N, Temple R. Zannad F, et al. Among authors: zariffa n. Heart. 2017 Aug;103(15):1156-1162. doi: 10.1136/heartjnl-2017-311191. Epub 2017 Apr 28. Heart. 2017. PMID: 28455296 Review.
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Vega DM, Nishimura KK, Zariffa N, Thompson JC, Hoering A, Cilento V, Rosenthal A, Anagnostou V, Baden J, Beaver JA, Chaudhuri AA, Chudova D, Fine AD, Fiore J, Hodge R, Hodgson D, Hunkapiller N, Klass DM, Kobie J, Peña C, Pennello G, Peterman N, Philip R, Quinn KJ, Raben D, Rosner GL, Sausen M, Tezcan A, Xia Q, Yi J, Young AG, Stewart MD, Carpenter EL, Aggarwal C, Allen J. Vega DM, et al. Among authors: zariffa n. JCO Precis Oncol. 2022 Aug;6:e2100372. doi: 10.1200/PO.21.00372. JCO Precis Oncol. 2022. PMID: 35952319 Free PMC article.
PhRMA perspective on population and individual bioequivalence.
Barrett JS, Batra V, Chow A, Cook J, Gould AL, Heller AH, Lo MW, Patterson SD, Smith BP, Stritar JA, Vega JM, Zariffa N. Barrett JS, et al. Among authors: zariffa n. J Clin Pharmacol. 2000 Jun;40(6):561-70. doi: 10.1002/j.1552-4604.2000.tb05980.x. J Clin Pharmacol. 2000. PMID: 10868305 Review.
Totality of evidence of the effectiveness of repurposed therapies for COVID-19: Can we use real-world studies alongside randomized controlled trials?
Mandema J, Montgomery H, Dron L, Fu S, Russek-Cohen E, Bromley C, Mouksassi S, Lalonde A, Springford A, Tsai L, Ambery P, McNair D, Qizilbash N, Pocock S, Zariffa N. Mandema J, et al. Among authors: zariffa n. Clin Transl Sci. 2023 Oct;16(10):1842-1855. doi: 10.1111/cts.13591. Epub 2023 Aug 28. Clin Transl Sci. 2023. PMID: 37466279 Free PMC article.
29 results